Amarin to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 January 2022 - 11:00PM
Amarin Corporation plc (NASDAQ: AMRN) today announced that Karim
Mikhail, president and chief executive officer of Amarin, is
scheduled to present virtually at the 40th Annual J.P. Morgan
Healthcare Conference on Tuesday, January 11, 2022, at 8:15 am ET.
A live webcast of the presentation will be accessible under
Events in the Investor Relations section of the company’s website
at https://investor.amarincorp.com/events-and-presentations/events.
The webcast will be archived for 30 days.
About Amarin Amarin is an innovative
pharmaceutical company leading a new paradigm in cardiovascular
disease management. From our foundation in scientific research to
our focus on clinical trials, and now our commercial expansion, we
are evolving and growing rapidly. Amarin has offices in
Bridgewater, New Jersey in the United States, Dublin in Ireland,
Zug in Switzerland, and other countries in Europe as well as
commercial partners and suppliers around the world. We are
committed to increasing the scientific understanding of the
cardiovascular risk that persists beyond traditional therapies and
advancing the treatment of that risk.
Availability of Other Information About
AmarinAmarin communicates with its investors and the
public using the company website (www.amarincorp.com) and the
investor relations website (investor.amarincorp.com), including but
not limited to investor presentations and FAQs, Securities and
Exchange Commission filings, press releases, public conference
calls and webcasts. The information that Amarin posts on these
channels and websites could be deemed to be material information.
As a result, Amarin encourages investors, the media and others
interested in Amarin to review the information that is posted on
these channels, including the investor relations website, on a
regular basis. This list of channels may be updated from time to
time on Amarin’s investor relations website and may include social
media channels. The contents of Amarin’s website or these channels,
or any other website that may be accessed from its website or these
channels, shall not be deemed incorporated by reference in any
filing under the Securities Act of 1933.
Amarin Contact Information
Investor Inquiries: Investor Relations Amarin Corporation plc In
U.S.: +1 (908) 719-1315 IR@amarincorp.com (investor inquiries)
Solebury Trout In U.S.: +1 (646) 378-2992
amarinir@troutgroup.com
Media Inquiries: Communications Amarin Corporation plc In U.S.:
+1 (908) 892-2028 PR@amarincorp.com (media inquiries)
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024